[1]郑剑峰 邱洪.冠状动脉钙化研究进展[J].心血管病学进展,2020,(4):338-340.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.002]
 ZHENG JianFengQIU Hong.Coronary Artery Calcification[J].Advances in Cardiovascular Diseases,2020,(4):338-340.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.002]
点击复制

冠状动脉钙化研究进展()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年4期
页码:
338-340
栏目:
综述
出版日期:
2020-04-25

文章信息/Info

Title:
Coronary Artery Calcification
作者:
郑剑峰 邱洪
(中国医学科学院 北京协和医学院 国家心血管病中心 阜外医院,北京 100037)
Author(s):
ZHENG JianFengQIU Hong
(Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100037, China)
关键词:
钙化冠状动脉冠状动脉钙化
Keywords:
Calcification Coronary arteryCoronary artery calcification
DOI:
10.16806/j.cnki.issn.1004-3934.2020.04.002
摘要:
冠状动脉钙化(coronary artery calcification,CAC)是导致一般人群和冠状动脉性心脏病患者不良结局的危险因素。CAC的发病机制和骨形成有共同的途径,目前已经确定了一些导致CAC发生和发展的危险因素。用药物治疗控制CAC的努力没有取得成功,而冠状动脉钙化的患者经皮冠脉介入术和冠状动脉搭桥术后的无事件生存率也较低。虽然应用药物洗脱支架和斑块修饰装置对钙化血管的预后有一定改善,但不良事件发生率仍然很高。在未来,仍需要创新的药物和器械治疗来改善CAC患者的不良预后。
Abstract:

Coronary artery calcification (CAC) is a risk factor for adverse outcomes in the general population and in patients with coronary artery disease. The pathogenesis of CAC shares a common pathway with bone formation, and some risk factors leading to the occurrence and development of CAC have been identified. Efforts to control CAC with medication have not been successful, and patients with coronary artery calcification have lower event-free survival after percutaneous coronary intervention and coronary artery bypass grafting. Although drug-eluting stents and plaque modifying devices have improved the prognosis of calcified vessels, the incidence of adverse events remains high. In the future, innovative drugs and devices are still needed to improve the poor prognosis of patients with CAC.

参考文献/References:


[1] Wang L,Jerosch-Herold M,Jacobs Jr DR, et al. coronary artery calcification and myocardial perfusion in asymptomatic adults. The MESA (Multi-Ethnic Study of Atherosclerosis)[J]. JAm Coll Cardiol,2006,48(5):1018-1026.

[2] Kalra SS,Shanahan CM. Vascular calcification and hypertension:cause and effect[J]. Ann Med,2012,44(Suppl 1):S85-S92.

[3] Demer LL,Tintut Y. Vascular calcification:pathobiology of a multifaceted disease[J]. Circulation,2008,117(22):2938-2948.

[4] Aikawa E,Nahrendorf M,Figueiredo JL,et al. Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo[J]. Circulation,2007,116(24):2841-2850.

[5] Abedin M,Tintut Y,Demer LL. Vascular calcification:mechanisms and clinical ramifications[J].Arterioscler Thromb Vasc Biol,2004,24(7):1161-1170.

[6] Doehring LC,Heeger C,Aherrahrou Z,et al. Myeloid CD34+CD13+ precursor cells transdifferentiate into chondrocyte-like cells in atherosclerotic intimal calcification[J]. Am J Pathol,2010,177(1):473-480.

[7] Bobryshev YV. Transdifferentiation of smooth muscle cells into chondrocytes in atherosclerotic arteries in situ: Implications for diffuse intimal calcification[J]. J Pathol,2005,205(5):641-650.

[8] Al-Aly Z,Shao JS,Lai CF,et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-α-dependent signals in diabetic Ldlr-/- mice[J]. Arterioscler Thromb Vasc Biol,2007,27(12):2589-2596.

[9] Chen NX,Duan D,O’Neill KD,et al. High glucose increases the expression of Cbfa1 and BMP-2 and enhances the calcification of vascular smooth muscle cells[J]. Nephrol Dial Transplant,2006,21(12):3435-3442.

[10] Neven E,Persy V,Dauwe S,et al. Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats[J]. Arterioscler Thromb Vasc Biol,2010,30(9):1741-1750.

[11] Neven E,D’Haese PC. Vascular calcification in chronic renal failure: What have we learned from animal studies?[J]. Circ Res,2011;108(2):249-264.

[12] Nakahara T,Dweck MR,Narula N,et al. Coronary artery calcification:from mechanism to molecular imaging[J]. JACC Cardiovasc Imaging,2017,10(5):582-593.

[13] Sakamoto A,Virmani R,Finn AV. Coronary artery calcification: recent developments in our understanding of its pathologic and clinical significance[J]. Curr Opin Cardiol,2018,33(6):645-652.

[14] Bailey G,Meadows J,Morrison AR. Imaging atherosclerotic plaque calcification: translating biology[J]. Curr Atheroscler Rep,2016,18(8):51.

[15] Hutcheson JD,Goettsch C,Bertazzo S,et al. Genesis and growth of extracellular-vesicle-derived microcalcification in atherosclerotic plaques[J]. Nat Mater,2016,15(3):335-343.

[16] Alique M,Ramirez-Carracedo R,Bodega G,et al. Senescent microvesicles: a novel advance in molecular mechanisms of atherosclerotic calcification[J]. Int J Mol Sci,2018,19(7):2003.

[17] Durham AL,Speer MY,Scatena M,et al. Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness[J]. Cardiovasc Res,2018,114(4):590-600.

[18] Bakhshian Nik A,Hutcheson JD,Aikawa E. Extracellular vesicles as mediators of cardiovascular calcification[J]. Front Cardiovasc Med,2017,4:78.

[19] Roijers RB,Debernardi N,Cleutjens JPM,et al. Microcalcifications in early intimal lesions of atherosclerotic human coronary arteries[J]. Am J Pathol,2011,178(6):2879-2887.

[20] Kelly-Arnold A,Maldonado N,Laudier D,et al. Revised microcalcification hypothesis for fibrous cap rupture in human coronary arteries[J]. Proc Natl Acad Sci U S A,2013,110(26):10741-10746.

[21] Madhavan MV,Tarigopula M,Mintz GS,et al. Coronary artery calcification: pathogenesis and prognostic implications[J]. J Am Coll Cardiol,2014,63(17):1703-1714.

[22] Kolodgie FD,Burke AP,Farb A,et al. The thin-cap fibroatheroma:a type of vulnerable plaque the major precursor lesion to acute coronary syndromes[J]. Curr Opin Cardiol,2001,16(5):285-292.

[23] Ghadri JR,Fiechter M,Fuchs TA,et al. Registry for the Evaluation of the PROgnostic value of a novel integrated imaging approach combining Single Photon Emission Computed Tomography with coronary calcification imaging (REPROSPECT)[J]. Eur Heart J Cardiovasc Imaging,2013,14(4):374-380.

[24] Bittl JA,Chew DP,Topol EJ,et al. Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy,cutting balloon atherotomy,or laser angioplasty[J]. J Am Coll Cardiol,2004,43(6):936-942.

[25] Kume T,Okura H,Kawamoto T,et al. Assessment of the histological characteristics of coronary arterial plaque with severe calcification[J]. Circ J,2007,71(5):643-647.

[26] Fernandez JP,Hobson AR,McKenzie D,et al. Beyond the balloon:excimer coronary laser atherectomy used alone or in combination with rotational atherectomy in the treatment of chronic total occlusions,non-crossable and non-expansible coronary lesions[J]. EuroIntervention,2013,9(2):243-250.

[27] Parikh K,Chandra P,Choksi N,et al. Safety and feasibility of orbital atherectomy for the treatment of calcified coronary lesions:The ORBIT Ⅰ Trial[J]. Catheter Cardiovasc Interv,2013,81(7):1134-1139.

[28] Ertelt K,Généreux P,Mintz GS,et al. Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the acute catheterization and urgent intervention triage strategy trial)[J]. Am J Cardiol,2013,112(11):1730-1737.

相似文献/References:

[1]鲁鹏,综述,蔡琳,等.冠状动脉钙化的研究新进展[J].心血管病学进展,2016,(2):176.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.021]
 LU Peng,CAI Lin,HUANG Wei.New Progress of Coronary Artery Calcification[J].Advances in Cardiovascular Diseases,2016,(4):176.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.021]
[2]孙一博 孙莉萍 董建增.血管炎的冠状动脉风险及手术治疗进展[J].心血管病学进展,2020,(8):821.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.010]
 SUN YiboSUN LipingDONG Jianzeng.Coronary Risk and Progress in Surgical Therapy of Vasculitis[J].Advances in Cardiovascular Diseases,2020,(4):821.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.010]
[3]田婷 罗俊一 杨毅宁.一种罕见的冠状动脉异常——编织样冠状动脉[J].心血管病学进展,2020,(9):943.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.014]
 TIAN Ting,LUO Junyi,YANG Yining.An Extremely Rare Anomaly of Coronary Artery[J].Advances in Cardiovascular Diseases,2020,(4):943.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.014]
[4]白梦雪 赵慧强.低分子右旋糖酐光学相干断层成像技术在冠状动脉疾病中的应用进展[J].心血管病学进展,2022,(2):103.[doi:10.16806/j.cnki.issn.1004-3934.20.02.003]
 BAI MengxueZHAO Huiqiang.Application of Low Molecular Dextran Optical Coherence Tomography?n Coronary Arteries Disease[J].Advances in Cardiovascular Diseases,2022,(4):103.[doi:10.16806/j.cnki.issn.1004-3934.20.02.003]
[5]陈璐 王国宏 郭彩霞.冠状动脉CT血管成像对冠心病预后预测价值及治疗策略指导意义[J].心血管病学进展,2022,(2):108.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.004]
 CHEN Lu,WANG Guohong,GUO Caixia.The Value of Coronary CT Angiography In Predicting the Prognosis and Treatment Strategies of Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2022,(4):108.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.004]
[6]李俊鹏 刘建 刘娜 杨欣荣 高婷 赵正凯.“三低”技术在CT体部血管一站式成像的应用价值[J].心血管病学进展,2022,(7):662.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
 LI Junpeng,LIU Jian,LIU Na,et al.Application of Three Lows Technology in One-Stop Imaging of CT Body Vessels[J].Advances in Cardiovascular Diseases,2022,(4):662.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[7]李依珂 高艳香 李青 郭紫玉 郑金刚.冠状动脉微循环侵入性检测方法研究进展[J].心血管病学进展,2023,(1):30.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.008]
 LI Yike,GAO Yanxiang,LI Qing,et al.Invasive Assessment of Coronary Microcirculation[J].Advances in Cardiovascular Diseases,2023,(4):30.[doi:10.16806/j.cnki.issn.1004-3934.2023.01.008]
[8]李明 张慧平.急性ST段抬高心肌梗死患者直接经皮冠状动脉介入治疗后微血管功能障碍再认识[J].心血管病学进展,2023,(3):193.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.001]
 LI Ming,ZHANG Huiping.Coronary Microvascular Dysfunction in Patients with Acute ST Segment?levation Myocardial Infarction After Primary Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2023,(4):193.[doi:10.16806/j.cnki.issn.1004-3934.2023.03.001]
[9]徐明成 赵玉娟.甘油三酯葡萄糖指数对动脉粥样硬化性心血管疾病的预测价值[J].心血管病学进展,2023,(9):810.[doi:10.16806/j.cnki.issn.1004-3934.202.09.010]
 Xu Mingcheng,ZHAO Yujuan.Predictive Value of Triglyceride Glucose Index in Atherosclerotic Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2023,(4):810.[doi:10.16806/j.cnki.issn.1004-3934.202.09.010]

备注/Memo

备注/Memo:
通讯作者:邱洪,E-mail:qiuhong6780@sina.com
收稿日期:2019-09-17
更新日期/Last Update: 2020-07-28